Study on Modified Xiaoyao Decoction combining Clomipramine treating depression / 中国中西医结合杂志

<p><b>OBJECTIVE</b>To observe the efficacy of Modified Xiaoyao Decoction (MXD) combining clomipramine in treatment of depression.</p><p><b>METHODS</b>One hundred and five depression patients were randomly assigned to two groups. The treated group (53 patients), all were differentiated as Gan-qi stagnation syndrome type and treated with MXD combining clomipramine 25-50 mg/d. The control group (52 patients) treated with clomipramine 75-225 mg/d alone. The treatment lasted for 8 weeks in both groups. Scores of depression was assessed with Hamilton Depression Scale (HAMD) before treatment and at the 2nd, 4th, 8th week of the treatment, efficacy and adverse reactions were evaluated with Global Impression of Change (CGI) and Treatment Emergent Symptom Scale (TESS) respectively.</p><p><b>RESULTS</b>After treatment the scores in both groups were significantly different from those before treatment (P < 0.01), but no significant difference was found between the two groups (P > 0.05). Main adverse reactions were dry mouth, constipation in the treated group, much less than those in the control group, which were mainly dry mouth, constipation, dizziness, insomnia, blurred vision and prolonged Q-T interval (P < 0.01).</p><p><b>CONCLUSION</b>MXD combining clomipramine has the efficacy on depression similar to clomipramine, but has less adverse reactions.</p>

Observation on therapeutic effect of electroacupuncture on obesity induced by antipsychotics / 中国针灸

<p><b>OBJECTIVE</b>To find out an effective therapy for obesity induced by antipsychotic agents.</p><p><b>METHODS</b>One hundred and one cases of obesity who were being treated with antipsychotic agents were randomly divided into an observation group and a control group. The observation group were treated with electroacupuncture at Quchi (LI 11), Zusanli (ST 36), Fenglong (ST 40), Shangjuxu (ST 37) and Xiajuxu (ST 39), once a day for 8 weeks; and no treatment was given to the control group. The Brief Psychiatric Rating Scale (BPRS) was used for assessment of therapeutic effect and the Treatment Emergent Symptom Scale (TESS) for adverse effects.</p><p><b>RESULTS</b>The clinically effective rate of the observation group (54.9%) was superior to the control group (10.0%) with a significant difference between the two groups (P<0.05). The BPRS score-reducing rate was 24.92% and 28.62% in the both groups respectively, and with no adverse effects.</p><p><b>CONCLUSION</b>Electroacupuncture has a good therapeutic effect on obesity induced by antipsychotic agents, and it improves the patient's compliance with no adverse effect.</p>